Tempus AI News - October 23, 2026

🟢 Tempus AI is trading 4.1% up today after $192.5 million agreements

Tempus AI is trading 4.09% up at $66.42, with the gain accompanying its October 23 announcement of agreements with Bristol Myers Squibb and Pathos AI. - The...

Tempus AI Announces $192.5M Data Licensing Agreements with Bristol-Myers Squibb and Pathos AI

Tempus AI has entered into a series of agreements with Bristol-Myers Squibb (BMS) and Pathos AI to expand the use of its de-identified multimodal real-world...